The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Clover Health Investments Corp shares valued at $999,596 were purchased by Garipalli Vivek on Aug 09 ’24. At $1.88 per share, Garipalli Vivek acquired 531,700 shares. The insider’s holdings grew to 1,409,267 shares worth approximately $4.45 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Garipalli Vivek purchased 877,567 shares, netting a total of over 1,000,426 in proceeds. Following the buying of shares at $1.14 each, the insider now holds 877,567 shares.
Before that, Loengard Anna U had added 17,085 shares to its account. In a trade valued at $16,372, the Director bought Clover Health Investments Corp shares for $0.96 each. Upon closing the transaction, the insider’s holdings increased to 17,085 shares, worth approximately $49296.0.
As published in their initiating research note from UBS on October 07, 2024, Clover Health Investments Corp [CLOV] has been a Neutral and the price target has been revised to $4. Analysts at Cowen upgraded the stock from ‘”an Underperform”‘ to ‘”a Market perform”‘ outlook in a report released in early February. As of February 02, 2022, Canaccord Genuity has initiated its “Buy” rating for CLOV. Earlier on January 19, 2022, SVB Leerink initiated its rating. Their recommendation was “a Mkt perform” for CLOV stock.
Analyzing CLOV Stock Performance
During the last five days, there has been a drop of approximately -27.36%. Over the course of the year, Clover Health Investments Corp shares have jumped approximately 231.90%. Shares of the company reached a 52-week high of $4.71 on 10/17/24 and a 52-week low of $0.61 on 04/22/24. A 50-day SMA is recorded $3.50, while a 200-day SMA reached $1.82. Nevertheless, trading volume fell to 6.01 million shares from 8.69 million shares the previous day.
Support And Resistance Levels for Clover Health Investments Corp (CLOV)
According to the 24-hour chart, there is a support level at 3.07, which, if violated, would cause prices to drop to 2.98. In the upper region, resistance lies at 3.30. The next price resistance is at 3.43. RSI (Relative Strength Index) is 33.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.62, which suggests the price will decrease in the coming days. Percent R is at 96.75%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
